ABCELLERA BIOLOGICS INC (ABCL) Forecast, Price Target & Analyst Ratings

NASDAQ:ABCL • CA00288U1066

Current stock price

3.54 USD
+0.1 (+2.91%)
At close:
3.56 USD
+0.02 (+0.56%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABCELLERA BIOLOGICS INC (ABCL).

Forecast Snapshot

Consensus Price Target

Price Target
$9.35
+ 164.13% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.19
Revenue Estimate
5.788M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.35
Upside
+ 164.13%
From current price of $3.54 to mean target of $9.35, Based on 14 analyst forecasts
Low
$7.07
Median
$9.69
High
$12.60

Price Target Revisions

1 Month
-6.78%
3 Months
-6.78%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ABCL. The average price target is 9.35 USD. This implies a price increase of 164.13% is expected in the next year compared to the current price of 3.54.
The average price target has been revised downward by 6.78% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ABCL Current Analyst RatingABCL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

ABCL Historical Analyst RatingsABCL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
ABCL was analyzed by 14 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ABCL.
In the previous month the buy percentage consensus was at a similar level.
ABCL was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10Jones TradingInitiate Buy
2025-11-07Leerink PartnersDowngrade Outperform -> Market Perform
2025-08-08StifelMaintains Buy -> Buy
2025-07-14KeybancMaintains Overweight -> Overweight
2025-05-16Truist SecuritiesMaintains Buy -> Buy
2025-04-16KeybancMaintains Overweight -> Overweight
2025-03-03BenchmarkReiterate Hold -> Hold
2025-02-28StifelMaintains Buy -> Buy
2025-01-08KeybancMaintains Overweight -> Overweight
2024-11-05BenchmarkReiterate Hold
2024-11-05StifelReiterate Buy -> Buy
2024-08-20BenchmarkDowngrade Buy -> Hold
2024-07-11KeybancMaintains Overweight -> Overweight
2024-05-08KeybancMaintains Overweight -> Overweight
2024-02-22BenchmarkUpgrade Hold -> Buy
2024-02-21StifelMaintains Buy -> Buy
2023-12-05KeybancInitiate Overweight
2023-08-31BenchmarkMaintains Buy -> Buy
2023-08-04Goldman SachsMaintains Buy -> Buy
2023-05-05Credit SuisseMaintains Outperform
2023-02-28Cowen & Co.Initiate Outperform
2023-02-22BMO CapitalMaintains Outperform
2023-02-22Credit SuisseReiterate Outperform
2023-01-06SVB LeerinkMaintains Outperform
2022-12-15Goldman SachsInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.19
Revenue Estimate
5.788M
Revenue Q2Q
36.67%
EPS Q2Q
-29.20%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
13.27%
Revenue (3 Months)
-29.58%
EPS (1 Month)
0.00%
EPS (3 Months)
-13.43%

Next Earnings Summary

ABCL is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.19 USD and the consensus revenue estimate is 5.79M USD.
The next earnings revenue estimate has been revised downward by 29.58% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ABCL revenue by date.ABCL revenue by date.
38.025M
-92.17%		28.833M
-24.17%		75.128M
160.56%		30.489M
-59.42%		37.794M
23.96%		37.652M
-0.38%		73.689M
95.71%		119.96M
62.79%		291.65M
143.12%		512.63M
75.77%		719.52M
40.36%
EBITDA
YoY % growth
ABCL ebitda by date.ABCL ebitda by date.
-212.812M
-187.08%		-223.917M
-5.22%		-194.932M
12.94%		-242.709M
-24.51%		-248.88M
-2.54%		-224.91M
9.63%		-223.278M
0.73%		-224.196M
-0.41%		-226.542M
-1.05%		N/AN/A
EBIT
YoY % growth
ABCL ebit by date.ABCL ebit by date.
-237.207M
-209.56%		-314.766M
-32.70%		-217.103M
31.03%		-277.816M
-27.97%		-277.275M
0.19%		-279.052M
-0.64%		-297.908M
-6.76%		-268.437M
9.89%		-112.224M
58.19%		69.461M
161.89%		240.97M
246.91%
Operating Margin
ABCL operating margin by date.ABCL operating margin by date.
-623.82%-1,091.69%-288.98%-911.20%-733.65%-741.14%-404.28%-223.77%-38.48%13.55%33.49%
EPS
YoY % growth
ABCL eps by date.ABCL eps by date.
-0.52
-204.00%		-0.55
-5.77%		-0.49
10.91%		-0.77
-57.86%		-0.82
-5.76%		-0.78
5.24%		-0.89
-14.47%		-0.61
31.03%		0.14
123.33%		1.29
800.00%		1.71
33.33%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.19
-29.20%		-0.19
-56.40%		-0.22
-15.96%		-0.20
-573.20%		-0.24
-26.32%		-0.24
-30.43%		-0.23
-6.48%		-0.23
-16.16%
Revenue
Q2Q % growth		5.788M
36.67%		7.701M
-54.92%		7.956M
-11.16%		8.803M
-80.37%		6.579M
13.67%		7.548M
-1.99%		8.364M
5.13%		9.741M
10.66%
EBITDA
Q2Q % growth		-60.18M
-4.97%		-64.464M
-66.22%		-57.63M
4.32%		-60.435M
-842.68%		-65.994M
-9.66%		-69.564M
-7.91%		-65.484M
-13.63%		-67.83M
-12.24%
EBIT
Q2Q % growth		-67.951M
-8.44%		-68.028M
-37.19%		-70.975M
6.95%		-70.091M
-145.23%		-80.267M
-18.12%		-79.176M
-16.39%		-77.69M
-9.46%		-75.708M
-8.01%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ABCL Yearly Revenue VS EstimatesABCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
ABCL Yearly EPS VS EstimatesABCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-16.52%
EPS Next 5 Year
-4.55%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1.15%
Revenue Next 5 Year
26.95%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
4.22%
EBIT Next 5 Year
2.56%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ABCELLERA BIOLOGICS INC / ABCL Forecast FAQ

What is the average price target for ABCELLERA BIOLOGICS INC (ABCL) stock?

14 analysts have analysed ABCL and the average price target is 9.35 USD. This implies a price increase of 164.13% is expected in the next year compared to the current price of 3.54.

What is the next earnings date for ABCL stock?

ABCELLERA BIOLOGICS INC (ABCL) will report earnings on 2026-05-06.

What are the consensus estimates for ABCL stock next earnings?

The consensus EPS estimate for the next earnings of ABCELLERA BIOLOGICS INC (ABCL) is -0.19 USD and the consensus revenue estimate is 5.79M USD.

How many analysts cover ABCELLERA BIOLOGICS INC (ABCL) stock?

The number of analysts covering ABCELLERA BIOLOGICS INC (ABCL) is 14.